LORRAINE CHIDESTER: Open Payments
NPI 1477019446 · JOHNSTON, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$407 in 30 payments from 11 companies in 2025. Trend: 2023 $927 · 2024 $762 · 2025 $407
Food & beverage: $407
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $174 |
| Vanda Pharmaceuticals Inc. | 2 | $58 |
| MDD US Operations, LLC | 2 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
| Tris Pharma Inc | 1 | $15 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
| Itamar Medical Inc | 1 | $14 |
Products named: VRAYLAR, FANAPT, Qelbree, REXULTI, Quviviq, TRINTELLIX, INGREZZA, COBENFY.
Industry payments across IA — which companies pay providers there.
